302 related articles for article (PubMed ID: 32053670)
1. Radiomics in predicting mutation status for thyroid cancer: A preliminary study using radiomics features for predicting BRAFV600E mutations in papillary thyroid carcinoma.
Yoon JH; Han K; Lee E; Lee J; Kim EK; Moon HJ; Park VY; Nam KH; Kwak JY
PLoS One; 2020; 15(2):e0228968. PubMed ID: 32053670
[TBL] [Abstract][Full Text] [Related]
2. Radiomics Study of Thyroid Ultrasound for Predicting
Kwon MR; Shin JH; Park H; Cho H; Hahn SY; Park KW
AJNR Am J Neuroradiol; 2020 Apr; 41(4):700-705. PubMed ID: 32273326
[TBL] [Abstract][Full Text] [Related]
3. The role of BRAFV600E mutation and ultrasonography for the surgical management of a thyroid nodule suspicious for papillary thyroid carcinoma on cytology.
Moon HJ; Kwak JY; Kim EK; Choi JR; Hong SW; Kim MJ; Son EJ
Ann Surg Oncol; 2009 Nov; 16(11):3125-31. PubMed ID: 19644722
[TBL] [Abstract][Full Text] [Related]
4. BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience.
Pelizzo MR; Boschin IM; Barollo S; Pennelli G; Toniato A; Zambonin L; Vianello F; Piotto A; Ide EC; Pagetta C; Sorgato N; Torresan F; Girelli ME; Nacamulli D; Mantero F; Mian C
Clin Chem Lab Med; 2011 Feb; 49(2):325-9. PubMed ID: 21175381
[TBL] [Abstract][Full Text] [Related]
5. Elevated BANCR expression levels have different effects on papillary thyroid carcinoma progression depending on the presence of the BRAFV600E mutation.
Stojanović S; Šelemetjev S; Đorić I; Rončević J; Janković Miljuš J; Živaljević V; Išić Denčić T
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1835-1842. PubMed ID: 32651027
[TBL] [Abstract][Full Text] [Related]
6. Nomogram Based on Shear-Wave Elastography Radiomics Can Improve Preoperative Cervical Lymph Node Staging for Papillary Thyroid Carcinoma.
Jiang M; Li C; Tang S; Lv W; Yi A; Wang B; Yu S; Cui X; Dietrich CF
Thyroid; 2020 Jun; 30(6):885-897. PubMed ID: 32027225
[No Abstract] [Full Text] [Related]
7. Predicting BRAFV600E mutations in papillary thyroid carcinoma using six machine learning algorithms based on ultrasound elastography.
Agyekum EA; Wang YG; Xu FJ; Akortia D; Ren YZ; Chambers KH; Wang X; Taupa JO; Qian XQ
Sci Rep; 2023 Aug; 13(1):12604. PubMed ID: 37537230
[TBL] [Abstract][Full Text] [Related]
8. Radiomics analysis of dual-energy CT-derived iodine maps for diagnosing metastatic cervical lymph nodes in patients with papillary thyroid cancer.
Zhou Y; Su GY; Hu H; Ge YQ; Si Y; Shen MP; Xu XQ; Wu FY
Eur Radiol; 2020 Nov; 30(11):6251-6262. PubMed ID: 32500193
[TBL] [Abstract][Full Text] [Related]
9. Strong immunoexpression of midkine is associated with multiple lymph node metastases in BRAFV600E papillary thyroid carcinoma.
Choi YW; Kim YH; Lee J; Soh EY; Park TJ; Kim JH
Hum Pathol; 2015 Oct; 46(10):1557-65. PubMed ID: 26297257
[TBL] [Abstract][Full Text] [Related]
10. Clinical Implication of Highly Sensitive Detection of the BRAFV600E Mutation in Fine-Needle Aspirations According to the Thyroid Bethesda System in Patients With Conventional Papillary Thyroid Carcinoma.
Seo JY; Choi JR; Moon HJ; Kim EK; Han KH; Kim H; Kwak JY
Ann Otol Rhinol Laryngol; 2015 May; 124(5):392-9. PubMed ID: 25404749
[TBL] [Abstract][Full Text] [Related]
11. Artificial intelligence to predict the BRAFV600E mutation in patients with thyroid cancer.
Yoon J; Lee E; Koo JS; Yoon JH; Nam KH; Lee J; Jo YS; Moon HJ; Park VY; Kwak JY
PLoS One; 2020; 15(11):e0242806. PubMed ID: 33237975
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the application of B-mode and strain elastography ultrasound in the estimation of lymph node metastasis of papillary thyroid carcinoma based on a radiomics approach.
Liu T; Ge X; Yu J; Guo Y; Wang Y; Wang W; Cui L
Int J Comput Assist Radiol Surg; 2018 Oct; 13(10):1617-1627. PubMed ID: 29931410
[TBL] [Abstract][Full Text] [Related]
13. BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer.
Romei C; Ciampi R; Faviana P; Agate L; Molinaro E; Bottici V; Basolo F; Miccoli P; Pacini F; Pinchera A; Elisei R
Endocr Relat Cancer; 2008 Jun; 15(2):511-20. PubMed ID: 18509003
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis.
Kim SK; Song KH; Lim SD; Lim YC; Yoo YB; Kim JS; Hwang TS
Thyroid; 2009 Feb; 19(2):137-41. PubMed ID: 19014278
[TBL] [Abstract][Full Text] [Related]
15. The clinical significance of BRAFV600E mutations in pediatric papillary thyroid carcinomas.
Li Y; Wang Y; Li L; Qiu X
Sci Rep; 2022 Jul; 12(1):12674. PubMed ID: 35879379
[TBL] [Abstract][Full Text] [Related]
16. Radiomic Model for Determining the Value of Elasticity and Grayscale Ultrasound Diagnoses for Predicting BRAF
Wang YG; Xu FJ; Agyekum EA; Xiang H; Wang YD; Zhang J; Sun H; Zhang GL; Bo XS; Lv WZ; Wang X; Hu SD; Qian XQ
Front Endocrinol (Lausanne); 2022; 13():872153. PubMed ID: 35527993
[TBL] [Abstract][Full Text] [Related]
17. [Correlation of conventional ultrasound features and related factors with BRAFV600E gene mutation in papillary thyroid carcinoma].
Lv Y; He X; Yang F; Guo L; Qi M; Zhang J; Wang H
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Oct; 35(10):925-929. PubMed ID: 34628817
[No Abstract] [Full Text] [Related]
18. Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer.
Song YS; Yoo SK; Kim HH; Jung G; Oh AR; Cha JY; Kim SJ; Cho SW; Lee KE; Seo JS; Park YJ
Endocr Relat Cancer; 2019 Jun; 26(6):629-641. PubMed ID: 30999281
[TBL] [Abstract][Full Text] [Related]
19. The role of BRAF V600E mutation as a potential marker for prognostic stratification of papillary thyroid carcinoma: a long-term follow-up study.
Daliri M; Abbaszadegan MR; Bahar MM; Arabi A; Yadollahi M; Ghafari A; Taghehchian N; Zakavi SR
Endocr Res; 2014; 39(4):189-93. PubMed ID: 24679337
[TBL] [Abstract][Full Text] [Related]
20. BRAF V600E mutation and microRNAs are helpful in distinguishing papillary thyroid malignant lesions: Tissues and fine needle aspiration cytology cases.
Zarkesh M; Zadeh-Vakili A; Akbarzadeh M; Nozhat Z; Fanaei SA; Hedayati M; Azizi F
Life Sci; 2019 Apr; 223():166-173. PubMed ID: 30890403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
